Abstract
Cryptococcosis, caused by Cryptococcus neoformans, has been demonstrated to be controlled by T helper (Th)1 cells while Th2 cells are associated with fungal growth and dissemination. Although cryptococcal immunoreactive protein antigens were previously identified, their association with Th1 or Th2 immune responses was not provided. In mice, Th1-dependent IFN-γ induces the production of IgG2a, whereas the Th2 cytokine IL-4 stimulates the expression of IgG1 rendering each isotype an indicator of the underlying Th cell response. Therefore, we performed an immunoproteomic study that distinguishes Th1- and Th2-associated antigens by their reactivity with Th1-dependent IgG2a or Th2-dependent IgG1 antibodies in sera from C. neoformans-infected wild-type mice. We additionally analysed sera from Th2-prone IL-12-deficient and Th1-prone IL-4Rα-deficient mice extending the results found in wild-type mice. In total, ten, four, and three protein antigens associated with IgG1, IgG2a, or both isotypes, respectively, were identified. Th2-associated antigens represent promising candidates for development of immunotherapy regimens, whereas Th1-associated antigens may serve as candidates for vaccine development. In conclusion, this study points to intrinsic immunomodulatory effects of fungal antigens on the process of Th cell differentiation based on the identification of cryptococcal protein antigens specifically associated with Th1 or Th2 responses throughout mice of different genotypes.
Similar content being viewed by others
Introduction
Cryptococcus neoformans, an encapsulated basidiomycetous yeast, is the main etiological agent of cryptococcosis, a systemic and potentially fatal fungal infection. C. neoformans is ubiquitously present in the environment, especially in pigeon guano, which is the main known ecological niche of this pathogen1,2. Pulmonary infection with C. neoformans usually occurs through inhalation of infectious spores or desiccated yeasts from the environment establishing a normally latent, asymptomatic or minimally symptomatic disease in immunocompetent individuals1,2,3, although the risk to develop chronic allergic diseases such as asthma, has been shown to be enhanced in rats and BALB/c mice experimentally infected with C. neoformans4,5. In contrast, in immunocompromised persons such as AIDS patients, solid organ transplant recipients, or patients receiving exogenous immunosuppression, unresolved or untreated pulmonary cryptococcosis may lead to dissemination affecting the central nervous system (CNS) and causing meningitis or meningoencephalitis with a high mortality rate1,6. With about a quarter of a million individuals affected with cryptococcal meningitis per year and over 180,000 attributable annual deaths, this fungal infection is still responsible for 15% of all AIDS-associated mortalities7.
It is well known that the main host defence mechanism to resolve cryptococcosis is cell-mediated immunity by suppressing the growth of the yeasts in the lungs, which impedes dissemination to the CNS8. While T helper (Th)1 cells play a central role in induction of a protective immune response against cryptococcal infection, Th2 cells producing interleukin (IL)-4, IL-13, and IL-5, are detrimental in infection with C. neoformans9,10. Interestingly, C. neoformans is able to subvert immunoprotection by suppressing cellular immune response and through induction of humoral Th2 cell mediated immunity, resulting in a permissive environment for cryptococcal growth, characterized by IL-4-dependent immunoglobulin (Ig)E production, IL-13 dependent mucus production by goblet cells, IL-5-dependent eosinophilia, and functional pulmonary impairment, which are also features typically described in asthma2,4,5,11. Despite the benefits of available antifungal drugs, the emergence of drug-resistant fungal strains and several side-effects resulting from long term medication and toxicity, limit their use12. Therefore, adjunctive immunotherapy together with antifungal treatment is a promising option for the future11. The identification of cryptococcal protein antigens is of great interest for the development of an antifungal vaccine11. Particularly the discrimination between antigens that induce protective cell-mediated immunity responses to cryptococcal infection and antigenic compounds that are detrimental in cryptococcosis could contribute to the identification of vaccine candidates and targets for specific immunotherapy, respectively, which may help to reduce fungal burden, preventing the spread of the yeast from the lungs and increase the survival rate of the patients11.
Previous studies have aimed to identify protective cryptococcal proteins and protein fractions by their reactivity with antibodies produced by mice immunized with a murine IFN-γ-expressing C. neoformans strain (H99γ) that were in consequence protected against a subsequent challenge infection with a C. neoformans wild-type strain13,14. In another study, immunoreactive proteins of C. gattii, the closest related species to C. neoformans and the second most common etiological agent of cryptococcosis, have been identified using antibodies from sera of naturally infected koalas15. However, those studies lack the specific discrimination between immunoprotective and immunopathologic properties of the antigen that are associated with either a Th1 or a Th2 response. We decided to use a proteomic approach involving two-dimensional (2D) gel electrophoresis and subsequent immunoblot, for the identification of Th1- and Th2-associated cryptococcal antigens based on the linkage of class switching in B cells with production of distinct Th cell cytokines16. Several murine studies firmly established that IL-4 regulates B cells for secretion of IgG1 antibodies, whereas interferon-γ stimulates the expression of IgG2a antibodies rendering either isotype an indicator of the underlying Th2 or Th1 response in mice16,17,18. Therefore, we chose to identify Th1- and Th2- associated antigens of C. neoformans by their reactivity specifically with either Th1-dependent IgG2a or Th2-dependent IgG1 from sera of infected wild-type and gene-deficient mice that lack either Th1 or Th2 responses. The proteomic approach allows separating the cellular proteins and the identification of immunoglobulins binding specific antigens19. Using this technique, distinct Th2- and Th1-associated fungal proteins were identified which are likely to play a role in shaping the Th cell response to C. neoformans and may be used for development of anti-fungal immunotherapy or vaccination regimens.
Results
Pulmonary infection with C. neoformans leads to dominant production of Th2-dependent IgG1 and IgE
In a BALB/c model of intranasal cryptococcal infection, IgG1/IgE and IgG2a have been shown to be valid indicators for preferential Th2 and Th1 responses, respectively5,20. Wild-type mice are susceptible to infection with the C. neoformans strain 18415,20, while IL-4Rα-deficient mice, characterized by a dominant Th1 and Th17 response, are resistant to pulmonary cryptococcal infection20. In contrast, IL-12p35- and IL-12p40-deficient mice do succumb significantly earlier to intranasal infection (unpublished data) accompanied by a stronger Th2 response similarly as previously published for intravenously infected IL-12-deficient mice21. Sera from wild-type and knock-out mouse lines were used in order to rigorously distinguish specific Th1- and Th2-associated cryptococcal antigens. Levels of total IgG1 and IgE increased significantly in mice of all genotypes after infection with C. neoformans, except for IgE levels in IL-4Rα-deficient mice, which are unable to produce IgE20, underlining the overall Th2-biased immune response to this pathogen (Fig. 1a,b). In contrast, IgG2a levels were not influenced by cryptococcal infection (Fig. 1c). Comparison of total immunoglobulin levels revealed an increased Th2 response for IL-12p35- and IL-12p40-deficient mice, evidenced by the higher levels of total IgE in comparison with wild-type mice and comparable levels of IgG1 (Fig. 1a,b). Opposite, infected IL-4Rα-deficient mice showed a marked diminution in their Th2-associated B cell response, with no production of IgE and notably lower levels of total IgG1 compared to wild-type mice (Fig. 1a,b), consistent with previously published experiments20. Among all three groups of infected mice, production of total Th1-dependent IgG2a was determined to be lower in IL-12-deficient mice, while IL-4Rα-deficient mice produced the highest levels of this IgG isotype, although without statistical significance (Fig. 1c). When comparing the total levels of IgG1 and IgG2a in sera from infected IL-12- and IL-4Rα-deficient mice, a significant negative correlation between IgG1 and IgG2a was found (r = −0.5077, p = 0.0058**), confirming the opposite Th phenotypes in the selected mutant mice, while in sera from infected wild-type mice, there was no correlation between the two IgG isotypes (data not shown).
After quantification of total immunoglobulin concentrations, the titers of C. neoformans-specific IgG1 and IgG2a antibodies were determined, using a cryptococcal antigen-specific enzyme-linked immunosorbent assay (ELISA). Compared to wild-type and IL-12-deficient mice, titers for specific IgG1 antibodies against C. neoformans were lower in infected IL-4Rα-deficient mice (Fig. 1d), while infected IL-12-deficient mice showed reduced levels of specific IgG2a antibodies compared to infected wild-type and IL-4Rα-deficient mice (Fig. 1e). Overall, titers for C. neoformans-specific IgG1 antibodies reached higher values in comparison to C. neoformans-specific IgG2a titers. Furthermore, titers of C. neoformans-specific IgG1 and IgG2a showed a significant increase upon cryptococcal infection for all genotypes except for IgG2a detected in sera of IL-12-deficient mice (Fig. 1d,e). C. neoformans-specific IgG1 and IgG2a antibodies were absent in sera from naïve mice of all genotypes (Fig. 1d,e). A strong correlation was found between total and specific levels of IgG1 (r = −0.6638, ****p < 0.0001, Fig. 1f) but not between total and specific levels of IgG2a (r = 0.2037, p = 0.1957, Fig. 1g) in sera from infected mice of all genotypes, indicating an influence of C. neoformans on the production of IgG1 but not IgG2a antibodies. We did not determine C. neoformans-specific IgE titers in serum samples, as these are expected to be very low according to a previous study22. In conclusion, we could confirm the previously observed Th2-tilted immune response on the level of both, total and specific IgG1 and IgG2a antibodies upon C. neoformans infection.
Proteomic analysis reveals cryptococcal antigens specifically reactive with IgG1 or IgG2a antibodies
After determining the titers for specific IgG1 and IgG2a antibodies against C. neoformans proteins, representative serum samples from each group of infected mice, five from wild-type and two from gene-deficient mice, were tested by immunoblot analyses following one-dimensional (1D) gel electrophoresis. Serum samples that showed high titers of C. neoformans-specific antibodies and titers around the median value were chosen. Additionally, serum samples from naïve mice (one per genotype) were included. As expected, detection of IgG1-reactive proteins after 1D sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of cryptococcal proteins and subsequent immunoblotting revealed several bands following incubation with sera from infected wild-type mice (Supplementary Fig. S1). No bands were visible after incubation of the membrane with sera from naïve wild-type mice, naïve IL-12-deficient mice and both, infected and naïve IL-4Rα-deficient mice (Supplementary Fig. S1). IL-12p35-deficient mice produced strong IgG1 responses, indicated by an increased number of IgG1-reactive protein bands visible after incubation with sera (Supplementary Fig. S1).
Analysis of IgG2a-reactive proteins revealed one band after incubation of the membrane with sera from naïve mice of all genotypes, indicating nonspecific reactivity with cryptococcal proteins (Supplementary Fig. S1). As expected, incubation with sera from infected mice of all genotypes resulted in additional protein bands, demonstrating that IgG2a antibodies recognized several C. neoformans proteins.
To achieve sufficient resolution for identification of individual C. neoformans proteins, 2D gel electrophoresis and subsequent immunoblot experiments were performed. We decided to analyse sera from five wild-type, four IL-12-deficient and four IL-4Rα-deficient mice. Only immunoreactive spots, which could be accurately mapped on the corresponding Coomassie-stained SDS gels were taken into account for further analysis. Representative immunoblots of individual mice, which display most but not all immunoreactive spots observed in a total of four to five mice, are shown in Figures 2 and 3. Nine IgG1-immunoreactive protein spots were detected using sera from infected wild-type mice (Fig. 2a, bold numbers). When using sera from infected IL-12p35-deficient mice, seven additional IgG1-immunoreactive protein spots were identified (Fig. 2c, bold numbers). Importantly, as already indicated by 1D gel analysis (Supplementary Fig. S1), no proteins were found to be IgG1-immunoreactive with sera from naïve wild-type and naïve IL-12p35-deficient mice (Fig. 2b,d). Most IgG1-immunoreactive spots could be identified in several individual mice of different genotypes (Fig. 5). Sera from IL-4Rα-deficient mice were not tested for IgG1-reactive antigens, as no immunoreactive bands were detected after 1D analysis (Supplementary Fig. S1). Nine protein spots were determined to be exclusively IgG2a-immunoreactive (Fig. 3a,c,e), from which five were considered IgG2a-immunoreactive but not C. neoformans-specific, as they also reacted with sera from naïve wild-type, IL-4Rα-deficient, and IL-12-deficient mice (Fig. 3b,d,f, light, underlined numbers). Three protein spots were identified as infection-specific when using serum from an infected wild-type mouse (Fig. 3a, bold, underlined numbers), which were not detectable using sera from IL-12deficient mice (Fig. 3e). In contrast, incubation with serum from infected IL-4Rα-deficient mice resulted in one additional spot (Fig. 3c). Notably, in contrast to IgG1-reactive proteins, infection-specific IgG2a-reactive spots only occurred in single animals without a high consistency (Fig. 5). To our surprise, only one protein spot (#18) was both IgG1- and IgG2a-immunoreactive in sera from infected wild-type mice. Few spots (#4–7, #17) were exclusively IgG1-immunoreactive in sera from infected wild-type mice (Fig. 2a,c, italic numbers), but showed reactivity with IgG2a when using serum from infected IL-4Rα-deficient mice (Fig. 3c, (spots #4–7 not shown)). In conclusion, this suggests that the host genotype in some cases (i.e. under strong Th cell polarizing conditions) affects the regulation of the Th-dependent isotype, but, in the wild-type host, fungal antigens significantly determine the Th cell phenotype. Immunoreactivity of the different proteins spots, seen by the intensity on the membrane, did not correlate with the abundancy of the proteins in the microorganism, as evidenced by Coomassie staining of the proteins in the gel (Fig. 4). This indicates that the given protein abundancy does not influence the degree of immunoreactivity.
Mass spectra analysis of the 31 immunoreactive protein spots (Fig. 4) led to the identification of 17 unique cryptococcal proteins, as different isoforms of the same protein were identified in more than one spot. The frequency of these proteins in C. neoformans-infected mice of different genotypes is displayed in Fig. 5. Ten cryptococcal proteins were determined to be exclusively Th2-associated antigens as they reacted specifically with IgG1 antibodies (Table 1, Fig. 5), while only three proteins were exclusively immunoreactive with Th1-dependent IgG2a among the C. neoformans-specific proteins (Table 2, Fig. 5). From the five spots that were not C. neoformans-specific, but also exclusively IgG2a-reactive, one protein was identified (Table 2, Fig. 5). Identification of the six protein spots reactive with both, IgG1 and IgG2a antibodies (#4–7, #17, #18) revealed three immunoreactive proteins (Table 3, Fig. 5). Tables 1–3 give an overview of the immunological characteristics of these proteins or family of proteins as reported in previous studies of fungal infections including cryptococcosis. The proteins identified herein have various functions in cellular metabolism, growth as well as stress resistance and virulence. Eight out of the 17 identified proteins were previously identified in immunoproteomic studies on immunoreactive antigens of C. neoformans and C. gattii13,14,15,23. Taken together, using a proteomic approach we could identify ten IgG1- and three IgG2a-reactive C. neoformans-specific antigens using sera from infected wild-type and gene-deficient mice, which can be associated with either Th2- or Th1-mediated immune responses.
Discussion
Cryptococcosis remains one of the prominent infectious diseases in both, industrialized and developing countries. Even though overall outcome of antifungal therapy is effective, the rates of morbidity, mortality and relapse episodes among cryptococcosis patients continue to be remarkably high7. The search for alternative treatments for this mycosis and the prevention of cryptococcal dissemination by immunotherapy or vaccination is therefore of significant importance. Previously, attempts have been made to establish a protective vaccine against cryptococcosis by using capsular polysaccharides for immunization of mice, which turned out to elicit immunological unresponsiveness24. This could be overcome by linking cryptococcal polysaccharides to carrier proteins (i.e. using conjugate vaccines). In contrast to carbohydrate antigens, immunoreactive protein antigens are capable of eliciting direct T cell-dependent responses25, which is critical for the control of cryptococcal infection. In contrast to previous studies identifying immunoreactive cryptococcal antigens13,14,15,26, the immunoproteomic approach utilized in the present study is the first of its kind for the discrimination of cryptococcal Th2- and Th1-associated antigens seen by their reactivity with antibodies of the murine isotypes IgG1 or IgG2a, respectively. We confirmed the previously observed capacity of the fungus to induce a biased Th2 response in BALB/c mice4,5 demonstrated by the significantly increased levels of total IgG1 and IgE levels upon infection with C. neoformans and higher levels of IgG1 than IgG2a antibodies specific for cryptococcal antigens. We also identified a larger number of IgG1-reactive C. neoformans-specific antigens, which also occurred with enhanced consistency throughout different animals in comparison to IgG2a-reactive C. neoformans-specific antigens.
The induction of Th2-tilted immune responses by C. neoformans has been associated with cell wall and capsular components such as chitin and glucuronoxylomannan27,28,29. In addition to these carbohydrate factors, several proteins have been identified, such as (i) Pik1, Rub1 and Ena1, which deletion resulted in a decreased Th2-response upon infection30, (ii) laccase and urease, which promoted Th2 polarization31,32, or (iii) Ssa1, that was shown to promote macrophage M2 skewing during the afferent phase of the immune response against C. neoformans33. From these immunomodulatory proteins, the Hsp70 protein Ssa1 (annotated as Hsp71-like protein) was also identified in our study.
Interestingly, we were able to identify distinct Th1- and Th2-associated cryptococcal antigens throughout mice of different genotypes, which seemingly contrasts the immunological paradigm that the process of Th cell differentiation is mainly influenced by the surrounding cytokine milieu rather than the immunogenic antigen34. As the differentiation of T cells occurs after the interaction with antigen-presenting cells (APCs)35, distinct antigens may influence APCs to produce certain cytokines driving either Th1- or Th2-differentiation. It is conceivable that cellular vs. secreted cryptococcal proteins could target different APCs. However, presently it is not clear which of the identified proteins are either cell-associated or secreted. Other parameters influencing Th cell differentiation are the dose and binding strength of the antigen to the T-cell receptor resulting in different strength of T-cell receptor signalling and therefore distinct activation of downstream signals and transcription factors34,36. At this point it remains unclear how the identified Th1- and Th2-associated immunoreactive fungal antigens exert their influence on immune cells, but we hypothesize distinct direct interactions with APCs during the process of T cell differentiation. Future experiments therefore will include direct stimulation of APCs and T cells with the identified recombinantly expressed Th1- or Th2-associated C. neoformans antigens and furthermore the recombinant antigens will be used in vivo for immunization of mice.
IgG1-specific antigens are promising targets for specific immunotherapies addressed to restrain Th2-type responses, which are associated with exacerbation of disease, by skewing the Th cell differentiation towards a protective Th1 response. The IgG1-immunoreactive antigens identified in our study include proteins that are essential for growth and virulence of C. neoformans as they are involved in metabolism, oxidative stress, protein synthesis, and to maintain cell wall integrity (Table 1, Fig. 5). From those, six proteins, phosphopyruvate hydratase (enolase), elongation factor 1-β, 14-3-3 protein, Hsp71-like protein (Ssa1), transaldolase and glyceraldehyde-3-phosphate dehydrogenase, have been previously reported to be immunogenic in C. neoformans and its sibling species C. gattii13,14,15,23,26, although their association with Th phenotypes remained unclear in these studies. Nevertheless, this supports the immunodominant nature of these proteins and their role in inducing a Th-dependent antibody response, therefore rendering them excellent candidates for future experiments. Surprisingly, Hsp71-like protein (Ssa1) is among those proteins reactive only with Th2-dependent IgG1 antibodies, although Ssa1 has been reported to influence the immune response to C. neoformans during the afferent phase, but not during the efferent phase, eliciting no influence on adaptive immune response33. Additionally to antigens previously identified, this is the first time that Hsp72-like protein, a member of the highly immunogenic Hsp70 family37, thioredoxin-dependent peroxide reductase and two uncharacterized proteins (expressed protein Q5K7Y6, uncharacterized protein J9W025) are recognized as immunoreactive antigens in cryptococcal species. The identification of Th2-associated pathogenic proteins is of major therapeutic interest as a recent study could show that infection with a C. neoformans mutant strain lacking three chitin deacetylases and therefore chitosan, a component of the fungal cell wall and virulence factor, led to the development of a predominant Th1-type response and as a consequence to robust protective immunity if challenged with a C. neoformans wild-type strain38. Similarly, infection of mice with C. neoformans mutants characterized by a decreased Th2 bias after deletion of the respective genes, resulted not only in a prolonged survival of the animals but also in a predominant Th1-mediated immune response and decreased dissemination to the CNS, although in these cases prolonged immunity was not tested30,31. The proteins identified in our study may therefore serve as targets for the generation of C. neoformans knock-out mutants that could be used for similar vaccination-challenge experiments.
Three C. neoformans-specific antigens were found to be associated with a Th1 response as they reacted specifically with IgG2a antibodies (Table 2, Fig. 5). The protein phosphoglucomutase has been described so far only in Aspergillus fumigatus as an antigen expressed during invasive aspergillosis39. Vaccination with recombinant Hsp60-like protein has been associated with an improved course of disease in murine Histoplasma capsulatum infections40, underlining the potential protective influence of Hsp60-like protein also witnessed by its association with Th1-dependent IgG2a antibodies. Pyruvate decarboxylase is, to our knowledge, newly recognized as a fungal antigen. Further studies are necessary to test these IgG2a-reactive antigens in vaccination approaches for induction of a protective Th1 immune response. The identified IgG2a-reactive but C. neoformans-unspecific antigen ATP synthase subunit β could also be of particular interest for future studies, as this protein could be cross-reactive with different fungal species. Given the fact that this antigen was exclusively IgG2a-reactive and reactive with sera from all mice tested, indicating an immunodominant role, this protein could represent an excellent candidate for a protective vaccine against C. neoformans and potentially other fungal species. Previous studies demonstrated that immunization using protein fractions of C. neoformans and C. gattii prolongs the survival of mice against pulmonary cryptococcal infection14,23, but it has not been possible to elicit long lasting and effective protection. This suggests that a future vaccine should consist of fungal antigens selected for association with a protective Th1-response, rather than whole protein preparations.
Three proteins, Hsp90-like protein, spermidine synthase, and an uncharacterized protein (J9VHM5), were recognized by both IgG1 and IgG2a antibodies (Table 3, Fig. 5). Hsp90 has been identified as major immunogenic antigen not only in C. neoformans13,14 but also in A. fumigatus39. Reactivity with both isotypes could depend on a high fungal or microbial immunogenicity as evidenced by the high number of individual mice recognizing these antigens. Our study is the first to compare cryptococcal antigens recognized by sera of individual mice in contrast to other studies, which used pooled sera for their investigations. We found that several immunoreactive proteins, especially IgG1- or IgG1- and IgG2a-reactive proteins were observed with a high consistency throughout sera of individual mice. A likely explanation for this observation is the uniform major histocompatibility complex (MHC) haplotype (H-2d) of BALB/c inbred mice used in this study. Other immunoproteomic studies also used BALB/c mice13,14 for their experiments, which resulted in the identification of a number of identical antigens, underlining the importance of the MHC haplotype for antigen recognition by Th cells and development of antimicrobial antibodies. A recent immunization/challenge study proposed to combine multiple protein antigens in light of a critical role of MHC-II haplotype diversity for protection41.
We chose to identify immunoreactive cryptococcal antigens using sera from mice infected with C. neoformans for at least 56 days to mimic a prolonged interaction of the fungus with the immune system, as it occurs within the human population. We do not expect a different pattern of immunoreactive proteins in earlier stages of infection, as hallmarks of a Th2-polarisation, like IL-13 and IL-5 production as well as expression of GATA3 in Th cells are present in wild-type mice infected with C. neoformans already on day 21 post infection (dpi)42. Furthermore, there was no obvious influence of the susceptibility and fungal burden on the pattern of immunoreactive proteins identified, as we could observe several proteins recognized by sera from mice of all genotypes despite their underlying predominant immune response, different courses of disease and fungal burden in the lung.
Although most of the proteins identified in this study are associated with cytoplasmic functions, it is known that proteins like 14-3-3 protein, heat shock proteins, pyruvate decarboxylase, and phosphopyruvate hydratase (enolase) can be found in the cell wall of fungi43,44. The protein export mechanisms of these proteins may serve to promote microbial interaction with the host to stimulate an immune response. As previously reported in other studies, no mannoproteins were found to be immunoreactive with either IgG1 or IgG2a antibodies14, indicating that the method used for protein extraction in this study may underrepresent these scarce proteins or other immunoreactive proteins45.
To conclude, our study resulted in the identification of a significant number of antigens that are associated with Th2-dependent IgG1 antibodies and potentially may serve for fungus-specific immunotherapy strategies. In addition, selected antigens reactive with Th1-dependent IgG2a can be used for protective immunization experiments. Besides, some of the identified Th1- or Th2-associated serological antigen-specific responses may have the potential to be used as diagnostic markers to monitor the prognosis or antifungal treatment response of patients with cryptococcosis. At the same time, the finding of distinct IgG1- and IgG2a-immunoreactive fungal proteins provides molecular candidates to study immunomodulatory mechanisms of fungal antigens during the process of Th cell differentiation.
Materials and Methods
Sera collection
Serum samples, obtained after at least 56 dpi from wild-type and gene-deficient adult female BALB/c mice (H-2d) previously infected by nasal inhalation with a single inoculum of 500 colony forming units of C. neoformans strain 1841 (serotype D) yeasts21, were utilized through the study. Sera from infected immunocompetent wild-type mice, which have shown to develop a strong Th2 response with high levels of IgE5,22, were tested. In addition, sera from infected IL-12-deficient mice (IL-12p35−/− and IL-12p40−/−), which present a strong Th2 biased immune response upon pulmonary infection with C. neoformans21 were included. Sera from infected IL-4Rα-deficient mice (IL-4Rα−/−), which show a reduced Th2-immune response in pulmonary cryptococcosis20,46 were also tested to enlighten the cryptococcal specific isotype production in a Th1 driven environment. All BALB/c wild-type mice succumbed to intranasal infection starting at 70 dpi (median survival time 74 dpi, unpublished data). In contrast, death of IL-12p35−/− and IL-12p40−/− mice started at significantly earlier time points (median survival time 52 dpi, unpublished data), whereas all IL-4Rα-deficient mice survived the pulmonary cryptococcal infection, but maintained detectable levels of cryptococcal cells in their lungs20. As negative controls sera from naïve mice of all three genotypes were used. Per group, 14 infected and 9–14 naïve mice from at least two different infection experiments were analysed. The mice were maintained under specific pathogen-free conditions, according to the guidelines authorized by the Animal Care and Usage Committee of the “Landesdirektion Sachsen” (www.lds.sachsen.de, Chemnitz, Germany) with food and water ad libitum. All infection experiments were carried out in accordance with the guidelines of the Committee of the “Landesdirektion Sachsen” according to the approved protocols with numbers 24-9168.11-TVV 5/01 and 24-9168.11 TVV 15/05.
Protein extraction
C. neoformans strain 1841 was recovered from 10% fetal calf serum stocks stored at −80 °C and grown for 48 h in Sabouraud dextrose agar medium while shaking gently at 30 °C. For ELISA, yeast cells were harvested by centrifugation and washed twice with 250 mM sucrose. After washing, yeast pellets were resuspended in lysis buffer containing 10 mM Tris/HCl pH 7.5 supplemented with 5 mM EDTA and 1x protease-inhibitor cocktail (Roche, Basel, Switzerland). Thereafter, the suspension was transferred into a lysis-tube containing a mix of 0.1 mm glass beads together with 1.4 mm ceramic beads (PEQLAB, Erlangen, Germany) and cells were lysed by homogenization in the Peqlab-homogenizer at 4 °C (Precellys® 24). The suspension was centrifuged twice transferring every time only the supernatant. The protein concentration was estimated using the Bradford reagent (Carl Roth, Karlsruhe, Germany) and samples were stored at −30 °C.
For one- and two-dimensional (1D and 2D) gel electrophoresis, some modifications were done to the protein extraction methodology in order to increase and maintain the solubility of the proteins. Yeast cells were harvested as previously mentioned and after washing, in addition to the lysis buffer, the pellets were mixed with an equal volume of a solution containing 8% CHAPS and 100 mM DTT. This suspension was disposed into a mortar and cells were frozen with liquid nitrogen and homogenized with a pestle twice. The homogenates were centrifuged and the protein suspensions were recovered. Protein content was estimated using the Bradford reagent (Carl Roth, Karlsruhe, Germany). Finally, proteins were precipitated overnight at −20 °C with 100% TCA (final concentration of 10% w/v) and washed three times with cold acetone to remove impurities or interfering substances. Pellet samples were kept at −30 °C until further analyses.
Immunoglobulin isotyping
Total levels of Th2-dependent IgG1 and IgE and Th1-dependent IgG2a were determined in mice sera as previously described5. Briefly, 96 well round button plates were coated overnight at 4 °C with goat anti-mouse-IgG1, -IgE or -IgG2a, respectively (SouthernBiotech, Birmingham, AL, USA) in carbonate buffer. The plates were washed once with phosphate buffered saline (PBS) containing 0.05% Tween-20 (PBST) and blocked with PBS containing 0.5% BSA and 0.1% gelatine for 1 h at room temperature. Mouse IgG1, IgE, and IgG2a (SouthernBiotech, Birmingham, AL, USA), were used as standards, respectively. Sera were diluted in blocking buffer containing 0.05% Tween-20 up to 1:25,000 for IgG1 and IgG2a and up to 1:90 for IgE. The plates were incubated with the serum samples for 1.5 h at room temperature and washed three times with PBST. Detection was done with goat antibodies labelled with horseradish peroxidase (HRP) and specific for mouse IgG1, IgE, and IgG2a, respectively (SouthernBiotech, Birmingham, AL, USA), diluted 1:4,000. After 2 h incubation, the plates were washed four times with PBST and developed with 3,3′,5,5′-tetramethylbenzidine (KPL, Gaithersburg, MD, USA). Immediately after the wells with the higher concentration of the standard antibody reached an OD of 1.3 at 650/480 nm, developing of the plates was stopped by adding 1M H3PO4. A final reading of the plates was done at 450/630 nm and the concentration of each immunoglobulin isotype was calculated per serum sample47.
Additionally, titers of C. neoformans-specific IgG1 and IgG2a antibodies were determined for all serum samples as previously described47, with some modifications. ELISA plates were coated overnight with 0.5 µg of C. neoformans 1841 protein extract per well. Blocking was done with 5% skim milk dissolved in PBS (SM). Sera from infected mice were diluted in SM containing 0.05% Tween-20 (SMT) starting from 1:100 up to 1:409,600 for IgG1, due to expected higher titers, and starting from 1:50 up to 1:25,600 for IgG2a. Sera from naïve mice were diluted in SMT starting from 1:50 up to 1:25,600 for both isotypes. Detection was done with goat anti-mouse IgG1, human ads-HRP or goat anti-mouse IgG2a, human ads-HRP, respectively (SouthernBiotech, Birmingham, AL, USA). Development of the plates was done with 3,3′,5,5′-tetramethylbenzidine (KPL, Gaithersburg, MD, USA) for 45 min at room temperature and stopped with H3PO4 prior to OD determination at 450/630 nm47. The titer of C. neoformans-specific immunoglobulins was defined as the highest dilution at which the OD still showed a linear reduction. ELISA experiments to determine C. neoformans-specific IgE titers were not carried out, as previous studies of our group indicate that the expected concentration of C. neoformans-specific IgE is very low22. For all ELISA experiments, wells incubated without serum samples but with all other reagents were used as blanks. All experiments were done in technical duplicates.
One-dimensional electrophoresis and immunoblot analysis
In order to assess the reactivity of serum IgG1 and IgG2a antibodies against specific cryptococcal proteins, one-dimensional (1D) SDS-PAGE and western blot were performed, according to methods previously described48,49. Briefly, C. neoformans protein pellets were dissolved in PBS to a final concentration of 1 mg/ml, mixed with the same volume of 2x Lämmli buffer and heated for 5 min at 95 °C. In each well of a 12.5% acrylamide gel 10 µg of protein were applied. Proteins were separated in Tris-glycine-SDS running buffer using the Owl™ Dual-Gel Vertical Electrophoresis Systems P8DS equipment (ThermoFisher Scientific, Waltham, MA, USA). For immunological detection, the separated proteins were transferred onto a nitrocellulose membrane by electroblotting using the Mini Trans-Blot equipment (BioRad, Hercules, CA, USA). After blotting, membranes were blocked overnight at 4 °C with 5% skim milk dissolved in distilled water (blocking buffer). Subsequently, membranes were incubated for 3 h at room temperature with sera from infected and naïve mice, respectively, diluted 1:1,000 in blocking buffer containing 0.1% Tween-20. Membranes were washed with PBST and incubated 1 h at room temperature with 1:4,000 goat anti-mouse IgG1 or goat anti-mouse IgG2a antibodies coupled to HRP (SouthernBiotech, Birmingham, AL, USA) to detect specific IgG1 or IgG2a antibodies, respectively, which bind to one or more C. neoformans proteins. Development of the membranes was done with SuperSignal® West Pico Chemiluminescent Substrate (ThermoFisher Scientific, Waltham, MA, USA).
Two-dimensional electrophoresis
Sera with C. neoformans specific immunoglobulin levels near to the median values of all samples of a genotype, in order to guarantee representative results for all samples, were further analysed by 2D gel electrophoresis. Additionally, serum samples with high titers of specific antibodies for C. neoformans were also investigated by 2D gel electrophoresis to see if sera with high titers are reactive with an increased number of C. neoformans proteins. In total, five serum samples from infected wild-type mice and four sera from infected mice of each gene-deficient mouse strain were studied. From naïve mice, one serum sample per genotype was included.
Per gel, a pellet of 100 µg of C. neoformans proteins was resuspended in 125 µl of rehydration buffer (7M urea, 2M thiourea, 4% CHAPS, 50 mM DTT, 1% BioLyte® (BioRad, Hercules, CA, USA), 0.001% bromophenol blue) and applied onto an IPG strip (BlueStrips 3–10 NL/7 cm, SERVA, Heidelberg, Germany). Strips were rehydrated for 6 h at room temperature and proteins were focused overnight using the PROTEAN IEF cell (BioRad, Hercules, CA, USA) under the following conditions: active rehydration, 50 V for 6 h; Step 1, 150 V, rapid ramp for 1 h; Step 2, 300 V, rapid ramp for 1 h; Step 3, 1,000 V, linear ramp for 1 h; Step 4, 3,000 V, linear ramp for 2 h; Step 5, 3,000 V, rapid ramp for 2 h; and Step 6, 500 V for 12 h. Following isoelectric focusing, strips were soaked twice in equilibration buffer containing 6M urea, 2% SDS, 50 mM Tris/HCl pH 8.8 and 20% glycerol for 15 min. For the first equilibration step 2% DTT was added to the equilibration buffer and for a second equilibration step 2.5% iodoacetamide was added to the equilibration buffer. After equilibration, strips were soaked briefly in Tris-glycine-SDS running buffer and placed separately on a 12.5% acrylamide SDS gel. Proteins were separated in a second dimension in the Owl™ Dual-Gel Vertical Electrophoresis Systems P8DS equipment (ThermoFisher Scientific, Waltham, MA, USA). Proteins in the gels were stained with Coomassie Brilliant Blue G250 dissolved in 10% acetic acid and 50% methanol and subsequently destained with a solution containing only 10% acetic acid and 50% methanol followed by washing with water, or alternatively transferred onto a nitrocellulose membrane for further detection of immunoreactive proteins, as described above. Membranes were incubated with sera from infected mice diluted 1:1,000 in blocking buffer containing 0.1% Tween-20. Sera from naïve mice diluted 1:500 were also tested.
Identification of proteins by mass spectrometry
Spots of interest were mapped by overlaying Ponceau-stained nitrocellulose membranes, immunoblots and Coomassie-stained gels. Mapping was carried out with the software Delta2D (DECODON, Greifswald, Germany). The spots were excised manually from Coomassie-stained gels and digested in situ with trypsin. As described previously50, the resulting peptides were eluted out of the gel, concentrated by vacuum centrifugation, and analysed using a hybrid mass spectrometer (QExactive HF, ThermoFisher Scientific, Waltham, MA, USA) equipped with a chip-based electrospray device (TriVersa NanoMate, Advion) and coupled to a nano-ultra-performance liquid chromatography system (Dionex UltiMate 3000 RS, ThermoFisher Scientific, Waltham, MA, USA). A mass spectra (MS) database search was conducted using the MaxQuant software (version 1.4.1.2)51 against a concentrated UniProt database, which contains all reviewed and unreviewed C. neoformans proteins (crytococcusneoformans.uniprot.fasta). For the search, the following parameters were included: trypsin digestion, up to two missed cleavages, fixed modifications: carbamidomethylation as well as oxidation and the following variable modifications: first search peptide tolerance of 10 ppm, FTMS/MS/MS match tolerance of 10 ppm, a minimum of two peptides/protein, including at least one unique protein.
Statistical analysis
Mann-Whitney U test was performed to determine the significance of the differences in the total level of immunoglobulins between wild-type, IL-12-deficient and IL-4Rα-deficient mice according with the ELISA results, as the data did not show a Gaussian distribution. Data are presented as individual points and medians. A nonparametric Spearman’s correlation test was done to determine the strength and direction of association between total and specific levels of IgG1 and IgG2a. The degree of significance was annotated as following: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. GraphPad PRISM v7 software was used for statistical analyses (GraphPad Software, La Jolla, CA, USA).
Data availability statement
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Kwon-Chung, K. J. et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb. Perspect. Med. 4, a019760 (2014).
Goldman, D. L. et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics. 107, E66 (2001).
Saha, D. C. et al. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin. Vaccine Immunol. 14, 1550–1554 (2007).
Goldman, D. L., Davis, J., Bommarito, F., Shao, X. & Casadevall, A. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection. Potential role for fungal pulmonary infection in the pathogenesis of asthma. J. Infect. Dis. 193, 1178–1186 (2006).
Müller, U. et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179, 5367–5377 (2007).
Pappas, P. G. Cryptococcal infections in non-HIV-infected patients. Trans. Am. Clin. Climatol. Assoc. 124, 61–79 (2013).
Rajasingham, R. et al. Global burden of disease of HIV-associated cryptococcal meningitis. An updated analysis. Lancet Infect. Dis (2017).
Huffnagle, G. B., Yates, J. L. & Lipscomb, M. F. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173, 793–800 (1991).
Price, M. S. & Perfect, J. R. Host defenses against cryptococcosis. Immunol. Invest. 40, 786–808 (2011).
Müller, U. et al. Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis. Mucosal Immunol. 5, 299–310 (2012).
Gullo, F. P. et al. Cryptococcosis: Epidemiology, fungal resistance, and new alternatives for treatment. Eur. J. Clin. Microbiol. Infect. Dis. 32, 1377–1391 (2013).
Lewis, R. E. Current concepts in antifungal pharmacology. Mayo Clin. Proc. 86, 805–817 (2011).
Young, M., Macias, S., Thomas, D. & Wormley, F. L. Jr. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics. 9, 2578–2588 (2009).
Chaturvedi, A. K., Weintraub, S. T., Lopez-Ribot, J. L. & Wormley, F. L. Jr. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics. 13, 3429–3441 (2013).
Jobbins, S. E. et al. Immunoproteomic approach to elucidating the pathogenesis of cryptococcosis caused by Cryptococcus gattii. J. Proteome Res. 9, 3832–3841 (2010).
Snapper, C. M. & Paul, W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236, 944–947 (1987).
Germann, T. et al. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23, 1762–1770 (1993).
Stevens, T. L. et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334, 255–258 (1988).
Benndorf, D. et al. Identification of spore allergens from the indoor mould Aspergillus versicolor. Allergy. 63, 454–460 (2008).
Müller, U. et al. A gene-dosage effect for interleukin-4 receptor alpha-chain expression has an impact on Th2-mediated allergic inflammation during bronchopulmonary mycosis. J. Infect. Dis. 198, 1714–1721 (2008).
Decken, K. et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66, 4994–5000 (1998).
Piehler, D. et al. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am. J. Pathol. 179, 733–744 (2011).
Chaturvedi, A. K. et al. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 9, e104316 (2014).
Kozel, T. R., Gulley, W. F. & Cazin, J. Jr. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect. Immun. 18, 701–707 (1977).
Pirofski, L. A. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol. 9, 445–451 (2001).
Martins, L. M. S. et al. Immunoproteomics and immunoinformatics analysis of Cryptococcus gattii. Novel candidate antigens for diagnosis. Future Microbiol. 8, 549–563 (2013).
Wiesner, D. L. et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 11, e1004701 (2015).
Almeida, G. M., Andrade, R. M. & Bento, C. A. M. The Capsular Polysaccharides of Cryptococcus neoformans Activate Normal CD4+ T Cells in a Dominant Th2 Pattern. J. Immunol. 167, 5845–5851 (2001).
Shoham, S., Huang, C., Chen, J. M., Golenbock, D. T. & Levitz, S. M. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166, 4620–4626 (2001).
He, X. et al. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination. Am. J. Pathol. 181, 1356–1366 (2012).
Qiu, Y. et al. Immune modulation mediated by cryptococcal laccase promotes pulmonary growth and brain dissemination of virulent Cryptococcus neoformans in mice. PLoS One. 7, e47853 (2012).
Osterholzer, J. J. et al. Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am. J. Pathol. 174, 932–943 (2009).
Eastman, A. J. et al. Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization. J. Immunol. 194, 5999–6010 (2015).
Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28, 445–489 (2010).
Chen, L. & Flies, D. B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227–242 (2013).
Jin, B., Sun, T., Yu, X.-H., Yang, Y.-X. & Yeo, A. E. T. The effects of TLR activation on T-cell development and differentiation. Clin. Dev. Immunol. 2012, 836485 (2012).
Kakeya, H. et al. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis. Clin. Exp. Immunol. 115, 485–490 (1999).
Upadhya, R. et al. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans. MBio. 7 (2016).
Denikus, N. et al. Fungal antigens expressed during invasive aspergillosis. Infect. Immun. 73, 4704–4713 (2005).
Gomez, F. J., Allendoerfer, R. & Deepe, G. S. Jr. Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect. Immun. 63, 2587–2595 (1995).
Specht, C. A. et al. Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species. MBio. 8 (2017).
Piehler, D. et al. The IL-33 receptor (ST2) regulates early IL-13 production in fungus-induced allergic airway inflammation. Mucosal Immunol. 9, 937–949 (2016).
Guimaraes, A. J., Frases, S., Gomez, F. J., Zancope-Oliveira, R. M. & Nosanchuk, J. D. Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect. Immun. 77, 1357–1367 (2009).
Nombela, C., Gil, C. & Chaffin, W. L. Non-conventional protein secretion in yeast. Trends Microbiol. 14, 15–21 (2006).
Pietrella, D. et al. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect. Immun. 69, 2808–2814 (2001).
Stenzel, W. et al. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am. J. Pathol. 174, 486–496 (2009).
Grahnert, A., Müller, U., von Buttlar, H., Treudler, R. & Alber, G. Analysis of asthma patients for cryptococcal seroreactivity in an urban German area. Med. Mycol. 53, 576–586 (2015).
Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227, 680–685 (1970).
Burnette, W. N. “Western blotting”. Electrophoretic transfer of proteins from sodium dodecyl sulfate–polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195–203 (1981).
Tomm, J. M. et al. Identification of new potential allergens from Nile perch (Lates niloticus) and cod (Gadus morhua). J. Investig. Allergol. Clin. Immunol. 23, 159–167 (2013).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
Schechtman, D., Tarrab-Hazdai, R. & Arnon, R. The 14-3-3 protein as a vaccine candidate against schistosomiasis. Parasite Immunol. 23, 213–217 (2001).
da Fonseca, C. A. et al. Two-dimensional electrophoresis and characterization of antigens from Paracoccidioides brasiliensis. Microbes Infect. 3, 535–542 (2001).
Gil, M. L., Dagan, S., Eren, R. & Gozalbo, D. Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model. Antonie Van Leeuwenhoek. 89, 345–350 (2006).
Pitarch, A. et al. Analysis of the serologic response to systemicCandida albicans infection in a murine model. Proteomics. 1, 550–559 (2001).
Tian, L. et al. Protective Efficacy of Coccidial Common Antigen Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) against Challenge with Three Eimeria Species. Front Microbiol. 8, 1245 (2017).
El Ridi, R., Shoemaker, C. B., Farouk, F., El Sherif, N. H. & Afifi, A. Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy. Infect. Immun. 69, 237–244 (2001).
Kakeya, H. et al. A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis. Infect. Immun. 65, 1653–1658 (1997).
Fernandez-Arenas, E., Molero, G., Nombela, C., Diez-Orejas, R. & Gil, C. Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis. Proteomics. 4, 1204–1215 (2004).
Chou, H. et al. The transaldolase, a novel allergen of Fusarium proliferatum, demonstrates IgE cross-reactivity with its human analogue. PLoS One. 9, e103488 (2014).
Chou, H. et al. Transaldolases are novel and immunoglobulin E cross-reacting fungal allergens. Clin. Exp. Allergy. 41, 739–749 (2011).
Acknowledgements
We thank Dr. Daniela Volke for her valuable advices for 2D gel electrophoresis and Maj Schuster for support in preparing samples for mass spectrometry. We are grateful to Prof. Alexander Dalpke for critical reading of the manuscript. We thank Prof. Uwe Völker and Dr. Leif Steil for support in the mapping of immunoreactive proteins. C.F. and A.E.G. were funded by non-profit organizations, i.e. C.F. was supported by a Georg Forster Research Fellowship from the Alexander von Humboldt Foundation, Germany, for Postdoctoral Researchers. A.E.G. was supported by a doctoral stipend from the Foundation of the German Economy (Stiftung der Deutschen Wirtschaft) and by funds from the Ph.D. program (“Doktorandenförderplatz”) of the University of Leipzig, Leipzig, Germany. We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.
Author information
Authors and Affiliations
Contributions
C.F., B.S., M.v.B., and G.A. designed the study; C.F., A.E.G., K.S., B.S., and U.M. performed experiments; C.F., A.E.G., K.S., and U.M. analysed data; K.S., U.M., F.B., and M.v.B. provided key reagents; C.F., A.E.G., U.M., and G.A. wrote the paper; C.F. and A.E.G. prepared the figures; all authors reviewed the results and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Firacative, C., Gressler, A.E., Schubert, K. et al. Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection. Sci Rep 8, 2681 (2018). https://doi.org/10.1038/s41598-018-21039-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-21039-z
This article is cited by
-
Modulation of T Cell Differentiation in Mice with COPD Combined with Lung Cancer Through Key Targets of PD-1 by Tao Hong Si Wu Tang
Applied Biochemistry and Biotechnology (2024)
-
Bakuchicin alleviates ovalbumin-induced allergic asthma by regulating M2 macrophage polarization
Inflammation Research (2024)
-
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells
npj Vaccines (2023)
-
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen
npj Vaccines (2023)
-
Metal arsenic mediated enhancement of type-2 immunity in brains with altered locomotive activities in mice with autism-like behavioral characteristics
Toxicological Research (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.